Transcriptional and post-transcriptional regulation of Sprouty1, a receptor tyrosine kinase inhibitor in prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 14, Issue 4, 2011, Pages 279-285

  Darimipourain, M ^a   Wang, S ^a   Ittmann, M ^b   Kwabi Addo, B ^a  

^a HOWARD UNIVERSITY CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

microRNAs; Spry1; transcription

Indexed keywords

DNA; EARLY GROWTH RESPONSE FACTOR 1; EARLY GROWTH RESPONSE FACTOR 3; MESSENGER RNA; MICRORNA 21; PROTEIN TYROSINE KINASE INHIBITOR; PROTEIN WTE; SPROUTY PROTEIN; SPROUTY1 PROTEIN; TRANS ACTING FACTOR; TUMOR PROTEIN; UNCLASSIFIED DRUG; WT1 PROTEIN;

3' UNTRANSLATED REGION; ANIMAL CELL; BINDING SITE; CONTROLLED STUDY; DNA METHYLATION; GENE INACTIVATION; GENE SILENCING; GENETIC CONSERVATION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN TARGETING; REVIEW; RNA BINDING; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MALE; MEMBRANE PROTEINS; MICRORNAS; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; RNA, MESSENGER; SEQUENCE ALIGNMENT; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 80955163793     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2011.33     Document Type: Review

References (38)

1. Kwabi-Addo B, Ozen M, Ittmann M. The role of fibroblast growth factors and their receptors in prostate cancer. Endocr Relat Cancer 2004; 11: 709-724. (Pubitemid 40065546)
2. Hacohen N, Kramer S, Sutherland D, Hiromi Y, Krasnow MA. Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 1998; 92: 253-263. (Pubitemid 28073048)
3. Casci T, Vinos J, Freeman M. Sprouty, an intracellular inhibitor of Ras signaling. Cell 1999; 96: 655-665. (Pubitemid 29122808)
4. Kramer S, Okabe M, Hacohen N, Krasnow MA, Hiromi Y. Sprouty: a common antagonist of FGF and EGF signaling pathways in Drosophila. Development 1999; 126: 2515-2525. (Pubitemid 29299020)
5. Reich A, Sapir A, Shilo B. Sprouty is a general inhibitor of receptor tyrosine kinase signaling. Development 1999; 126: 4139-4147. (Pubitemid 29481570)
6. Minowada G, Jarvis LA, Chi CL, Neubuser A, Sun X, Hacohen N et al. Vertebrate sprouty genes are induced by FGF signaling and can cause chondrodysplasia when overexpressed. Development 1999; 126: 4465-4475.
7. de Maximy AA, Nakatake Y, Moncada S, Itoh N, Thiery JP, Bellusci S. Cloning and expression pattern of a mouse homo-logue of drosophila sprouty in the mouse embryo. Mech Dev 1999; 81: 213-216. (Pubitemid 29183064)
8. Hanafusa H, Torii S, Yasunaga T, Nishida E. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat Cell Biol 2002; 4: 850-858. (Pubitemid 35331359)
9. Gross I, Bassit B, Benezra M, Licht JD. Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation. J Biol Chem 2001; 276: 46460-46468.
10. Yigzaw Y, Cartin L, Pierre S, Scholich K, Patel TB. The C terminus of sprouty is important for modulation of cellular migration and proliferation. J Biol Chem 2001; 276: 22742-22747.
11. Impagnatiello MA, Weitzer S, Gannon G, Compagni A, Cotten M, Christofori G. Mammalian Sprouty-1 and-2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. J Cell Biol 2001; 152: 1087-1098. (Pubitemid 34286083)
12. Sasaki A, Taketomi T, Wakioka T, Kato R, Yoshimura A. Identification of a dominant negative mutant of sprouty that potentiates fibroblast growth factor-but not epidermal growth factor-induced ERK activation. J Biol Chem 2001; 276: 36804-36808.
13. Sasaki A, Taketomi T, Kato R, Saeki K, Nonami A, Sasaki M et al. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Nat Cell Biol 2003; 5: 427-432. (Pubitemid 36592265)
14. Kim HJ, Bar-Sagi D. Modulation of signalling by sprouty: a developing story. Nat Rev Mol Cell Biol 2004; 5: 441-450. (Pubitemid 38745494)
15. Lim J, Yusoff P, Wong ES, Chandramouli S, Lao DH, Fong CW et al. The cysteine-rich sprouty translocation domain targets mitogen-activated protein kinase inhibitory proteins to phos-phatidylinositol 4,5-bisphosphate in plasma membranes. Mol Cell Biol 2002; 22: 7953-7966. (Pubitemid 35217304)
16. Panagiotaki N, Dajas-Bailador F, Amaya E, Papalopulu N, Dorey K. Characterisation of a new regulator of BDNF signalling, Sprouty3, involved in axonal morphogenesis in vivo. Development 2010; 137: 4005-4015.
17. Kwabi-Addo B, Wang J, Erdem H, Vaid A, Castro P, Ayala G et al. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Res 2004; 64: 4728-4735. (Pubitemid 38924514)
18. Wang J, Thompson B, Ren C, Ittmann M, Kwabi-Addo B. Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer. Prostate 2006; 66: 613-624.
19. McKie AB, Douglas DA, Olijslagers S, Graham J, Omar MM, Heer R et al. Epigenetic inactivation of the human Sprouty2 (hSPRY2) homologue in prostate cancer. Oncogene 2005; 24: 2166-2174. (Pubitemid 40516583)
20. Kwabi-Addo B, Ren C, Ittmann M. DNA methylation and aberrant expression of Sprouty1 in human prostate cancer. Epigenetics 2009; 4: 54-61.
21. Zimarino V, Wu C. Induction of sequence-specific binding of Drosophila heat shock activator protein without protein synthesis. Nature 1987; 327: 727-730. (Pubitemid 17085910)
22. Rosa AL, Wu YQ, Kwabi-Addo B, Coveler KJ, Reid SV, Shaffer LG. Allele-specific methylation of a functional CTCF binding site upstream of MEG3 in the human imprinted domain of 14q32. Chromosome Res 2005; 13: 809-818. (Pubitemid 41768771)
23. Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995; 23: 4878-4884. (Pubitemid 3008389)
24. Gong QH, Stern J, Dean A. Transcriptional role of a conserved GATA-1 site in the human epsilon-globin gene promoter. Mol Cell Biol 1991; 11: 2558-2566. (Pubitemid 21895635)
25. Eid MA, Kumar MV, Iczkowski KA, Bostwick DG, Tindall DJ. Expression of early growth response genes in human prostate cancer. Cancer Res 1998; 58: 2461-2468. (Pubitemid 28252710)
26. Ibanez-Tallon I, Ferrai C, Longobardi E, Facetti I, Blasi F, Crippa MP. Binding of Sp1 to the proximal promoter links constitutive expression of the human uPA gene and invasive potential of PC3 cells. Blood 2002; 100: 3325-3332. (Pubitemid 35217084)
27. Kamps MP, Murre C, Sun XH, Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 1990; 60: 547-555.
28. Svoboda M, Riha J, Wlcek K, Jaeger W, Thalhammer T. Organic anion transporting polypeptides (OATPs): regulation of expression and function. Curr Drug Metab 2011; 12: 139-153.
29. Morris JF, Madden SL, Tournay OE, Cook DM, Sukhatme VP, Rauscher III FJ. Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. Oncogene 1991; 6: 2339-2348. (Pubitemid 21924083)
30. Nakagama H, Heinrich G, Pelletier J, Housman DE. Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Mol Cell Biol 1995; 15: 1489-1498.
31. Ding W, Bellusci S, Shi W, Warburton D. Functional analysis of the human Sprouty2 gene promoter. Gene 2003; 322: 175-185. (Pubitemid 37485994)
32. Ding W, Bellusci S, Shi W, Warburton D. Genomic structure and promoter characterization of the human Sprouty4 gene, a novel regulator of lung morphogenesis. Am J Physiol Lung Cell Mol Physiol 2004; 287: L52-L59. (Pubitemid 38787650)
33. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008; 456: 980-984.
34. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
35. Ozaki K, Kadomoto R, Asato K, Tanimura S, Itoh N, Kohno M. ERK pathway positively regulates the expression of sprouty genes. Biochem Biophys Res Commun 2001; 285: 1084-1088. (Pubitemid 32912891)
36. Baron V, Duss S, Rhim J, Mercola D. Antisense to the early growth response-1 gene (Egr-1) inhibits prostate tumor development in TRAMP mice. Ann NY Acad Sci 2003; 1002: 197-216. (Pubitemid 38253343)
37. Baron V, De GG, Krones-Herzig A, Virolle T, Calogero A, Urcis R et al. Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo. Oncogene 2003; 22: 4194-4204. (Pubitemid 36876240)
38. Bohm M, Locke WJ, Sutherland RL, Kench JG, Henshall SM. A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes. Oncogene 2009; 28: 3847-3856.